Picture of DarioHealth logo

DRIO — DarioHealth News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

DarioHealth Corp expected to post a loss of 40 cents a share - Earnings Preview

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
fall
in quarterly revenue when it reports  results on May 15 for the
period ending March 31 2024
    * The New York City-based  company is expected to report a
4.4% decrease in revenue to $6.758 million from $7.07 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for DarioHealth Corp is for
a loss
of 40 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 2.4%
in the last three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $5.00​, above​ its last closing price of $1.60. ​​​

This summary was machine generated May 7 at 14:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on DarioHealth

See all news